Arthur J. Benvenuto
Chief Executive Officer at Micell Technologies, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Daniel Estay | M | - |
Micell Technologies, Inc.
 Micell Technologies, Inc. Pharmaceuticals: MajorHealth Technology Micell Technologies, Inc. operates as a biomedical device company. It develops interventional cardiology systems for vascular drug delivery. The firm offers MiStent SES is designed to optimize healing in patients with coronary artery disease. The company was founded by Joseph M. DeSimone and James B. McClain in 1995 and is headquartered in Durham, NC. | - |
| Kenneth Langone | M | 88 |
Micell Technologies, Inc.
Micell Technologies, Inc. Pharmaceuticals: MajorHealth Technology Micell Technologies, Inc. operates as a biomedical device company. It develops interventional cardiology systems for vascular drug delivery. The firm offers MiStent SES is designed to optimize healing in patients with coronary artery disease. The company was founded by Joseph M. DeSimone and James B. McClain in 1995 and is headquartered in Durham, NC. | - |
| Robert Langer | M | 74 |
Micell Technologies, Inc.
Micell Technologies, Inc. Pharmaceuticals: MajorHealth Technology Micell Technologies, Inc. operates as a biomedical device company. It develops interventional cardiology systems for vascular drug delivery. The firm offers MiStent SES is designed to optimize healing in patients with coronary artery disease. The company was founded by Joseph M. DeSimone and James B. McClain in 1995 and is headquartered in Durham, NC. | - |
| Michael Stansky | M | 64 |
Micell Technologies, Inc.
Micell Technologies, Inc. Pharmaceuticals: MajorHealth Technology Micell Technologies, Inc. operates as a biomedical device company. It develops interventional cardiology systems for vascular drug delivery. The firm offers MiStent SES is designed to optimize healing in patients with coronary artery disease. The company was founded by Joseph M. DeSimone and James B. McClain in 1995 and is headquartered in Durham, NC. | - |
| Dennis J. Donohoe | M | 72 |
Micell Technologies, Inc.
Micell Technologies, Inc. Pharmaceuticals: MajorHealth Technology Micell Technologies, Inc. operates as a biomedical device company. It develops interventional cardiology systems for vascular drug delivery. The firm offers MiStent SES is designed to optimize healing in patients with coronary artery disease. The company was founded by Joseph M. DeSimone and James B. McClain in 1995 and is headquartered in Durham, NC. | - |
| John W. Lowry | M | - |
Micell Technologies, Inc.
Micell Technologies, Inc. Pharmaceuticals: MajorHealth Technology Micell Technologies, Inc. operates as a biomedical device company. It develops interventional cardiology systems for vascular drug delivery. The firm offers MiStent SES is designed to optimize healing in patients with coronary artery disease. The company was founded by Joseph M. DeSimone and James B. McClain in 1995 and is headquartered in Durham, NC. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| David A. Dresner | M | - |
Micell Technologies, Inc.
Micell Technologies, Inc. Pharmaceuticals: MajorHealth Technology Micell Technologies, Inc. operates as a biomedical device company. It develops interventional cardiology systems for vascular drug delivery. The firm offers MiStent SES is designed to optimize healing in patients with coronary artery disease. The company was founded by Joseph M. DeSimone and James B. McClain in 1995 and is headquartered in Durham, NC. | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 7 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Arthur J. Benvenuto
- Personal Network
